Europeum

RTVS | EU leaders discussed the new European Commission

June 17, 2024

On Monday, June 17, an informal meeting of the 27 member states of the European Union took place. Their leaders discussed the nominations of members for the new European Commission. Ursula von der Leyen will also have to compete for her position as President of the European Commission again. Viktor Daněk, Deputy Director of EUROPEUM Institute, discussed her chances on the Slovak television RTVS.

The Parliament Magazine | From Pfizer to Pieper: With von der Leyen on the defensive, who stands to gain?

April 22, 2024

Two recent controversies – Pfizergate and Piepergate – have thrown a wrench into Ursula von der Leyen’s re-election bid for the European Commission presidency. What impacts will they have and who will benefit form them? Žiga Faktor, head of EUROPEUM´s Institute Brussels office, comments in an article for The Parliament Magazine.

iRozhlas.cz | Pfizergate: Transparency or Privacy Protection?

April 04, 2024

Recent investigation into the purchase of Pfizer vaccines by the EU has revealed the involvement of Ursula von der Leyen, President of the European Commission, raising questions about transparency and accountability. With the interconnection of several cases, including allegations of undisclosed agreements and legal actions, attention to negotiation processes and financial management within the Commission is increasing. The outcomes of these investigations may influence public trust and future leadership of the EU, highlighting the delicate balance between transparency and privacy protection. Žiga Faktor, Deputy Director and Head of the Brussels Office of the EUROPEUM Institute, offered a commentary for iRozhlas.cz.

TN.cz | Ursula von der Leyen and Pfizergate

April 02, 2024

European Commission President Ursula von der Leyen faces charges related to the purchase of Covid-19 vaccines from Pfizer. The first information came from the The New York Times, which has subpoenaed European Commission documents relating to the negotiations for the purchase of the vaccines. Žiga Faktor, deputy director and head of the EUROPEUM Institute's Brussels office, commented on the case for TN.cz.